Developer docs
API playgroundTry for free, no card

Search company profiles

Miami Cancer Institute

Full company profile

uuid0042tph

Namestring
Miami Cancer Institute
Legal namestring
Baptist Health South Florida
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Miami Cancer Institute, operating as Baptist Health Herbert Wertheim Cancer Institute, is a non-profit comprehensive oncology center and a department of Baptist Hospital of Miami within the Baptist Health South Florida system. It serves adult and pediatric cancer patients across South Florida, delivering multidisciplinary care under one roof that spans diagnostics, medical oncology, radiation therapy, surgical oncology, interventional oncology, genomic medicine, and clinical trials, supported by an integrated suite of patient services including navigation, integrative medicine, brain fitness, oncology nutrition, psychosocial oncology, and a survivorship program.

Its core technology stack centers on advanced radiation therapy platforms, image-guided interventional oncology procedures, and a Center for Genomic Medicine that enables personalized treatment selection; an active clinical trials program and AAHRPP-accredited research infrastructure extend access to experimental therapies. The PineApp mobile application on iOS and Android provides a digital patient engagement layer for scheduling and care management. The institute is Florida's only member of the Memorial Sloan Kettering Cancer Alliance, giving its physicians direct collaboration with national cancer care leaders and protocol transfer.

The business model is non-profit healthcare delivery, with revenue generated from patient care services billed through insurance plans or self-pay under a pay-as-you-go model, supplemented by charitable care and financial assistance programs. Customers are individual patients (adult and pediatric) reached via physician referrals, a centralized phone scheduling line (786-596-2000), and online appointment requests, with referring physicians serving as a secondary professional channel. The institute relies on the parent Baptist Health South Florida system for administrative scale, brand, and digital marketing infrastructure across web, social media, podcasts, and community events.

Short descriptiontext

Miami Cancer Institute (Baptist Health Herbert Wertheim Cancer Institute) is a non-profit comprehensive oncology center in Miami serving adult and pediatric cancer patients across South Florida, and is Florida's only member of the Memorial Sloan Kettering Cancer Alliance.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersMiami, United States
HQ citystring
Miami
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
oncology treatment services, cancer care center, radiation oncology, hematology services, cancer clinical trials
Industry4 codes
1Oncology & Cancer Specialty Hospitals
CodeHLAFAHACPrimaryYes
2Medical Oncology
CodeHLAKAFABPrimaryNo
3Gynecologic Oncology & Women’s Cancer Centers
CodeHLAFAJAKPrimaryNo
4Oncology Specialty Pharmaceuticals
CodeHLAIACAAPrimaryNo
NAICS code2 codes
  • Specialty (except Psychiatric and Substance Abuse) Hospitals622310
  • Offices of Physicians62111
SIC code2 codes
  • Services-Hospitals8060
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
Cancer Treatment Services (Oncology Services)
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Patient Care Services
TypeSubscription Recurring
Description

Revenue generated from comprehensive cancer treatment services including diagnostics, chemotherapy, radiation therapy, surgical oncology, and supportive care services provided to patients with insurance coverage or self-pay arrangements.

baptisthealth.net:443
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Pricing details1 tier
1Healthcare services billed through insurance or self-pay based on services rendered
ModelOtherBilling cadencePay-as-you-go
Notes

No public pricing available. Services are billed through insurance plans or as self-pay. Good Faith Estimates available for uninsured patients. Financial assistance programs exist.

baptisthealth.net:443
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Miami Cancer Institute is a comprehensive, multi-disciplinary cancer treatment center providing medical oncology, radiation oncology, surgical oncology, hematology, and pediatric oncology services to adult and pediatric patients. Operating as part of Baptist Health South Florida, it integrates subspecialty care, supportive services, genomic medicine, and clinical trials (including Memorial Sloan Kettering Cancer Alliance protocols) at a single South Florida location.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 11 High Performing ratings from U.S. News & World Report for various cancer types
+1 more record
Product overview1 text field

Miami Cancer Institute, operating as Baptist Health Herbert Wertheim Cancer Institute, is a comprehensive cancer care center offering a unified platform of treatment and support services. The core clinical services include Adult Cancers Treatment and Pediatric Cancers Treatment, supported by specialized modalities such as Radiation Therapies, Oncology Infusion Care, Interventional Oncology, and a Center for Genomic Medicine. The institute provides access to Clinical Trials & Research for cutting-edge treatments. Patient support is delivered through an integrated network of services including the Patient Navigation Program, Integrative Medicine (acupuncture, massage, exercise), Brain Fitness Lab, Oncology Nutrition, Psychosocial Oncology, Survivorship Program, and Cancer Connect peer support. Prevention & Screening services enable early detection. A mobile application (PineApp) extends access to patients via iOS and Android platforms.

Product and service2 records
1Medical Oncology
CategoryMedical Oncology
2Radiation Oncology
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Miami Cancer Institute (Herbert Wertheim Cancer Institute) is Florida's only member of the Memorial Sloan Kettering Cancer Alliance. This partnership allows physicians to collaborate with national cancer care leaders to provide patients with the best cancer care locally. The alliance also enables knowledge sharing to improve cancer care now and for future generations.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Moffitt is Florida's only NCI-designated Comprehensive Cancer Center, operating as a standalone specialty cancer hospital in Tampa. It is the closest geographic peer and the most direct competitor for complex cancer referrals, clinical trial enrollment, and physician talent across the state.

TypeBroad incumbent
Description

Mayo's cancer center in Jacksonville (and Rochester/Arizona) is a peer comprehensive cancer program with multi-site operations, deep clinical trials activity, and a destination brand. Comparable in service mix and reputation tier; competes for Florida oncology patients and physician referrals.

TypeBroad incumbent
Description

Cleveland Clinic operates a national cancer program with multiple sites including Florida (Weston). Comparable in offering integrated multidisciplinary oncology care, genomic medicine, and clinical trials within a large non-profit health system, and competes in the same Florida market.

TypeDirect peer
Description

Florida Cancer Specialists is a large community-based oncology practice network providing medical oncology, hematology, infusion, and clinical trial access across Florida. It is a direct competitor for outpatient and community oncology referrals, particularly for patients who do not need hospital-based specialty services.

TypeBroad incumbent
Description

MSK is the parent alliance partner and a global benchmark in oncology. Comparable in providing comprehensive cancer treatment, radiation, surgery, genomic medicine, and clinical trials at scale; however, MSK is a destination national center operating multi-site across the Northeast rather than a regional South Florida provider.

TypeDirect peer
Description

Sylvester is an NCI-designated cancer center located in the same Miami market, affiliated with the University of Miami Health System. It competes head-to-head for South Florida cancer patients, subspecialty referrals, and academic/research talent.

TypeBroad incumbent
Description

Dana-Farber is a leading specialty cancer hospital offering comprehensive adult and pediatric oncology, research-driven care, and clinical trials. Comparable in scope and tertiary/quaternary cancer service mix, though it operates in the Northeast market.

TypeRegional player
Description

AdventHealth operates a multi-state non-profit cancer service line with central Florida presence and growing Florida footprint. Comparable as a system-affiliated comprehensive cancer program competing for regional referrals, though its core market (Orlando/Central Florida) is partially distinct from South Florida.

TypeBroad incumbent
Description

Kimmel is an NCI-designated Comprehensive Cancer Center offering the full range of oncology services, clinical trials, and genomic medicine. Comparable as an academic comprehensive cancer center; competes indirectly for destination patients and for top specialist talent.

TypeBroad incumbent
Description

MD Anderson is the largest U.S. cancer center and a destination for complex and rare cancers. Directly comparable in offering multidisciplinary oncology care, radiation therapy, infusion, genomics, and one of the largest clinical trial portfolios; but operates as a national/international destination rather than regional provider.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses3 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Miami Cancer Institute

Cancer Treatment Services (Oncology Services)cancer.baptisthealth.net

Miami Cancer Institute (Baptist Health Herbert Wertheim Cancer Institute) is a non-profit comprehensive oncology center in Miami serving adult and pediatric cancer patients across South Florida, and is Florida's only member of the Memorial Sloan Kettering Cancer Alliance.

What Miami Cancer Institute does

Miami Cancer Institute, operating as Baptist Health Herbert Wertheim Cancer Institute, is a non-profit comprehensive oncology center and a department of Baptist Hospital of Miami within the Baptist Health South Florida system. It serves adult and pediatric cancer patients across South Florida, delivering multidisciplinary care under one roof that spans diagnostics, medical oncology, radiation therapy, surgical oncology, interventional oncology, genomic medicine, and clinical trials, supported by an integrated suite of patient services including navigation, integrative medicine, brain fitness, oncology nutrition, psychosocial oncology, and a survivorship program.

Its core technology stack centers on advanced radiation therapy platforms, image-guided interventional oncology procedures, and a Center for Genomic Medicine that enables personalized treatment selection; an active clinical trials program and AAHRPP-accredited research infrastructure extend access to experimental therapies. The PineApp mobile application on iOS and Android provides a digital patient engagement layer for scheduling and care management. The institute is Florida's only member of the Memorial Sloan Kettering Cancer Alliance, giving its physicians direct collaboration with national cancer care leaders and protocol transfer.

The business model is non-profit healthcare delivery, with revenue generated from patient care services billed through insurance plans or self-pay under a pay-as-you-go model, supplemented by charitable care and financial assistance programs. Customers are individual patients (adult and pediatric) reached via physician referrals, a centralized phone scheduling line (786-596-2000), and online appointment requests, with referring physicians serving as a secondary professional channel. The institute relies on the parent Baptist Health South Florida system for administrative scale, brand, and digital marketing infrastructure across web, social media, podcasts, and community events.

Miami Cancer Institute firmographics

Firmographics
Name
Miami Cancer Institute
Legal name
Baptist Health South Florida
Website
https://cancer.baptisthealth.net
Company type
Private
Operating status
Operating
Headcount range
251–500 employees
Short description
Miami Cancer Institute (Baptist Health Herbert Wertheim Cancer Institute) is a non-profit comprehensive oncology center in Miami serving adult and pediatric cancer patients across South Florida, and is Florida's only member of the Memorial Sloan Kettering Cancer Alliance.
Ownership category
akta.pro rank

Miami Cancer Institute industry classification

Industry
Product category
Cancer Treatment Services (Oncology Services)
NAICS
Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Offices of Physicians (62111)
SIC
Services-Hospitals (8060), Services-Offices & Clinics Of Doctors Of Medicine (8011)
akta.pro primary industry
Oncology & Cancer Specialty Hospitals (HLAFAHAC)
akta.pro secondary industries
Medical Oncology (HLAKAFAB), Gynecologic Oncology & Women’s Cancer Centers (HLAFAJAK), Oncology Specialty Pharmaceuticals (HLAIACAA)

Keywords

  • Oncology treatment services
  • Cancer care center
  • Radiation oncology
  • Hematology services
  • Cancer clinical trials

Where Miami Cancer Institute is headquartered

Location

Headquarters

HQ city
Miami
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Miami Cancer Institute business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Patient Care Services: Revenue generated from comprehensive cancer treatment services including diagnostics, chemotherapy, radiation therapy, surgical oncology, and supportive care services provided to patients with insurance coverage or self-pay arrangements.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goHealthcare services billed through insurance or self-pay based on services rendered

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Miami Cancer Institute product offering

Product offering

Core offering

Miami Cancer Institute is a comprehensive, multi-disciplinary cancer treatment center providing medical oncology, radiation oncology, surgical oncology, hematology, and pediatric oncology services to adult and pediatric patients. Operating as part of Baptist Health South Florida, it integrates subspecialty care, supportive services, genomic medicine, and clinical trials (including Memorial Sloan Kettering Cancer Alliance protocols) at a single South Florida location.

Product overview

Miami Cancer Institute, operating as Baptist Health Herbert Wertheim Cancer Institute, is a comprehensive cancer care center offering a unified platform of treatment and support services. The core clinical services include Adult Cancers Treatment and Pediatric Cancers Treatment, supported by specialized modalities such as Radiation Therapies, Oncology Infusion Care, Interventional Oncology, and a Center for Genomic Medicine. The institute provides access to Clinical Trials & Research for cutting-edge treatments. Patient support is delivered through an integrated network of services including the Patient Navigation Program, Integrative Medicine (acupuncture, massage, exercise), Brain Fitness Lab, Oncology Nutrition, Psychosocial Oncology, Survivorship Program, and Cancer Connect peer support. Prevention & Screening services enable early detection. A mobile application (PineApp) extends access to patients via iOS and Android platforms.

Differentiator

Problem solved

Functional benefit

Products and services

  • Medical Oncology
  • Radiation Oncology

Quantifiable outcome

  • 11 High Performing ratings from U.S. News & World Report for various cancer types
  • +1 more outcomes

Companies that use Miami Cancer Institute

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles1 record

Miami Cancer Institute technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Miami Cancer Institute partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Memorial Sloan Kettering Cancer AllianceflagshipStrategic or Co-development PartnerMiami Cancer Institute (Herbert Wertheim Cancer Institute) is Florida's only member of the Memorial Sloan Kettering Cancer Alliance. This partnership allows physicians to collaborate with national cancer care leaders to provide patients with the best cancer care locally. The alliance also enables knowledge sharing to improve cancer care now and for future generations.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Miami Cancer Institute competitors and assessment

Company assessment

Direct peers

  • Moffitt Cancer Center: Moffitt is Florida's only NCI-designated Comprehensive Cancer Center, operating as a standalone specialty cancer hospital in Tampa. It is the closest geographic peer and the most direct competitor for complex cancer referrals, clinical trial enrollment, and physician talent across the state.
  • Florida Cancer Specialists & Research Institute: Florida Cancer Specialists is a large community-based oncology practice network providing medical oncology, hematology, infusion, and clinical trial access across Florida. It is a direct competitor for outpatient and community oncology referrals, particularly for patients who do not need hospital-based specialty services.
  • Sylvester Comprehensive Cancer Center (University of Miami): Sylvester is an NCI-designated cancer center located in the same Miami market, affiliated with the University of Miami Health System. It competes head-to-head for South Florida cancer patients, subspecialty referrals, and academic/research talent.

Broad incumbents

  • Mayo Clinic Comprehensive Cancer Center: Mayo's cancer center in Jacksonville (and Rochester/Arizona) is a peer comprehensive cancer program with multi-site operations, deep clinical trials activity, and a destination brand. Comparable in service mix and reputation tier; competes for Florida oncology patients and physician referrals.
  • Cleveland Clinic Cancer Center: Cleveland Clinic operates a national cancer program with multiple sites including Florida (Weston). Comparable in offering integrated multidisciplinary oncology care, genomic medicine, and clinical trials within a large non-profit health system, and competes in the same Florida market.
  • Memorial Sloan Kettering Cancer Center: MSK is the parent alliance partner and a global benchmark in oncology. Comparable in providing comprehensive cancer treatment, radiation, surgery, genomic medicine, and clinical trials at scale; however, MSK is a destination national center operating multi-site across the Northeast rather than a regional South Florida provider.
  • Dana-Farber Brigham Cancer Center: Dana-Farber is a leading specialty cancer hospital offering comprehensive adult and pediatric oncology, research-driven care, and clinical trials. Comparable in scope and tertiary/quaternary cancer service mix, though it operates in the Northeast market.
  • Johns Hopkins Sidney Kimmel Cancer Center: Kimmel is an NCI-designated Comprehensive Cancer Center offering the full range of oncology services, clinical trials, and genomic medicine. Comparable as an academic comprehensive cancer center; competes indirectly for destination patients and for top specialist talent.
  • MD Anderson Cancer Center: MD Anderson is the largest U.S. cancer center and a destination for complex and rare cancers. Directly comparable in offering multidisciplinary oncology care, radiation therapy, infusion, genomics, and one of the largest clinical trial portfolios; but operates as a national/international destination rather than regional provider.

Regional players

  • AdventHealth Cancer Institute: AdventHealth operates a multi-state non-profit cancer service line with central Florida presence and growing Florida footprint. Comparable as a system-affiliated comprehensive cancer program competing for regional referrals, though its core market (Orlando/Central Florida) is partially distinct from South Florida.

Market position

Strengths5 records

Weaknesses3 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Miami Cancer Institute social profiles

Digital presence

Miami Cancer Institute compliance and trust

Trust signal

Compliance3 records

Miami Cancer Institute financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Miami Cancer Institute leadership team

Management profile

Number of profiles

Profiles1 record

Miami Cancer Institute funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Miami Cancer Institute M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Miami Cancer Institute

What does Miami Cancer Institute do?

Miami Cancer Institute is a comprehensive, multi-disciplinary cancer treatment center providing medical oncology, radiation oncology, surgical oncology, hematology, and pediatric oncology services to adult and pediatric patients. Operating as part of Baptist Health South Florida, it integrates subspecialty care, supportive services, genomic medicine, and clinical trials (including Memorial Sloan Kettering Cancer Alliance protocols) at a single South Florida location.

Is Miami Cancer Institute a public or private company?

Miami Cancer Institute is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Miami Cancer Institute founded?

Miami Cancer Institute was founded in -1. It employs 251 to 500 people.

Where is Miami Cancer Institute based?

Miami Cancer Institute is headquartered in Miami, United States, in the North America region.

How does Miami Cancer Institute make money?

One revenue line is on record: patient Care Services.

Who are Miami Cancer Institute's main competitors?

Direct peers on record are Moffitt Cancer Center, Florida Cancer Specialists & Research Institute and Sylvester Comprehensive Cancer Center (University of Miami). Broad incumbents are Mayo Clinic Comprehensive Cancer Center, Cleveland Clinic Cancer Center, Memorial Sloan Kettering Cancer Center, Dana-Farber Brigham Cancer Center, Johns Hopkins Sidney Kimmel Cancer Center and MD Anderson Cancer Center. AdventHealth Cancer Institute is listed as a regional player.

Does Miami Cancer Institute have an API?

No public API is recorded for Miami Cancer Institute.

What industry is Miami Cancer Institute in?

Miami Cancer Institute's product category is Cancer Treatment Services (Oncology Services). Its primary akta.pro industry code is HLAFAHAC, Oncology & Cancer Specialty Hospitals, with a secondary code of HLAKAFAB, Medical Oncology. Its NAICS code is 622310 and its SIC code is 8060.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireRenovoRx’s PanTheR Post-Marketing Registry Study Progresses with First Clinical Procedure and Addition of Two Participating Clinical SitesRenovoRx announced the first registry-eligible patient procedure in its PanTheR Post-Marketing Registry Study was completed at the University of Vermont Cancer Center. Baptist Health Miami Cancer Institute and University of Pittsburgh Medical Center joined as participating sites. The study will gather real-world safety and survival data for RenovoCath in solid tumors.Technology Solutions That Drive HealthcareMiami Cancer Institute Delivers Precision Care with Health ITThe Miami Cancer Institute is utilizing a new tool called IntelliSpace Precision Medicine Genomics to improve cancer treatment through personalized data analysis. Developed by Philips, this tool combines DNA sequencing and deep learning to create tailored treatment plans based on comprehensive genomic information. The process enhances the ability of oncologists to interpret complex genetic data, thereby informing the selection of targeted therapies and clinical trial options for patients.The Indian ExpressShivarajkumar returns to Bengaluru after surgery in the USA; Karnataka CM Siddaramaiah meets the superstarKannada actor Shivarajkumar has returned to Bengaluru following successful bladder cancer surgery performed at the Miami Cancer Institute in the USA. Karnataka Chief Minister Siddaramaiah and fellow actors met with him upon his return as he prepares to resume his film career.The Indian ExpressKannada star Shivarajkumar cancer-free after surgery, shares emotional message for New Year. WatchKannada actor Shivarajkumar announced he is cancer-free following successful bladder cancer surgery and chemotherapy at the Miami Cancer Institute in December. He shared an emotional message thanking his family, fans, and medical staff for their support during his recovery.PR NewswireCantex and Miami Cancer Institute Announce FDA Clearance for a Clinical Trial Investigating Azeliragon Combined with Stereotactic Radiosurgery for the Treatment of Brain MetastasesCantex Pharmaceuticals and Miami Cancer Institute announced that the U.S. FDA issued a 'Study May Proceed' letter for a clinical trial investigating azeliragon combined with stereotactic radiosurgery for treating brain metastases. This authorization allows the investigator-initiated trial to assess whether azeliragon can improve radiation therapy effectiveness and reduce the need for steroids to control brain swelling. The move expands Cantex's investigation of azeliragon into new cancer indications, building on previous approvals for glioblastoma studies.PR NewswireMRIdian Clinical Studies and Initial MRIdian A3i Clinical Experience to be Highlighted at ASTRO 2022ViewRay, Inc. announced that its MRIdian MRI-Guided Radiation Therapy System will be featured at the 64th Annual ASTRO Meeting (October 23-26, 2022) in San Antonio, Texas, with clinical presentations on the SMART Pancreas study for pancreatic cancer and the MIRAGE Phase III randomized trial comparing MR-guided versus CT-guided SBRT for prostate cancer. The company will also highlight initial clinical experience with the new MRIdian A3i system, which features expanded real-time tissue tracking, automated beam gating, and new automated workflow tools designed to increase patient throughput. ViewRay will host an industry event featuring experts from Henry Ford Health System and Miami Cancer Institute, and an evening reception with journalist Katie Couric as part of its national awareness campaign partnership.PR NewswireDebbie's Dream Foundation: Curing Stomach Cancer Joins Miami Cancer Institute to Host a Virtual Stomach Cancer Educational SymposiumDebbie's Dream Foundation: Curing Stomach Cancer (DDF) and Miami Cancer Institute, part of Baptist Health South Florida, are co-hosting a virtual stomach cancer educational symposium on August 27, 2022, from 9:00 a.m. to 4:00 p.m. EST. Medical experts from Miami Cancer Institute will present on genetics, treatment options, surgical and non-surgical approaches, nutrition, and survivorship for gastric cancer patients. South Florida has been identified as a region with significantly higher gastric cancer mortality rates compared to other areas, prompting this collaborative educational initiative.GlobeNewswireMiami Cancer Institute First in World to Deliver Adaptive MR-Guided Radiation Therapy with the MRIdian® A3i SystemMiami Cancer Institute became the first in the world to use the MRIdian A3i system for adaptive MR-guided radiation therapy, treating a pancreas cancer patient. The system adjusts daily radiation doses to account for anatomical changes, potentially cutting treatment times by 40-50 percent.PR NewswireCaris' Precision Oncology Alliance Welcomes Miami Cancer InstituteCaris Life Sciences announced that Miami Cancer Institute, part of Baptist Health South Florida, has joined the Caris Precision Oncology Alliance, a growing network of leading cancer centers collaborating to advance precision oncology and biomarker-driven research. Miami Cancer Institute, recognized by U.S. News & World Report as being in the top 10% of cancer programs in the U.S., brings significant research capabilities to the alliance, which now includes 69 cancer centers and academic institutions. The alliance provides members with access to Caris' extensive clinico-genomic database and artificial intelligence platform, enabling evidence-based standards for cancer profiling and molecular testing.PR NewswireMiami Cancer Institute se convierte en el primer y único centro de terapia de protones acreditado por APEx en el estado de FloridaMiami Cancer Institute, part of Baptist Health South Florida, received full APEx accreditation from ASTRO for a four-year period effective August 10, 2021. The institute is now the first and only APEx-accredited proton therapy center in Florida, joining a select group of seven radiotherapy facilities in the state that hold this distinction. The accreditation recognizes the institute's systems, staff, policies, and procedures for delivering high-quality oncology care.